Xavier Loyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xavier Loyer has a total of 715 co-authors. Here are the top co-authors by number of shared publications:
Alain Tedgui
Université de Paris, PARCC, INSERM, F-75015, Paris, France
16 shared publications- Chantal M. Boulanger
INSERM, U970, Paris Cardiovascular Research Center-PARCC, Paris, France
15 shared publications - Christophe Heymes
UMR1297 Inserm/Université Paul Sabatier|Team InCOMM/Intestine ClinicOmics Metabolism & Microbiota – Institut des Maladies Métaboliques et Cardiovasculaires (I2MC)
13 shared publications - Ziad Mallat
Department of Medicine, Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK
11 shared publications Bruno Esposito
From the Inserm U970, Paris Cardiovascular Research Center (PARCC), Université René Descartes Paris 5, France
7 shared publications- Jane-Lise Samuel
Hopital Lariboisière
7 shared publications
Latest Publications
- Open Access
- 20 December 2021
- Published by EDP Sciences in médecine/sciences
- Vol. 37 (12) , 1119-1124
Vésicules extracellulaires et maladies cardiovasculaires
Les maladies cardiovasculaires constituent la principale cause de décès dans le monde. Il est donc urgent de développer de nouvelles approches pour le traitement et la détection de ces maladies. Les vésicules extracellulaires (VE) ont attiré une attention considérable au vu de leur rôle dans la communication intercellulaire. Elles régulent en effet des processus clés comme l’inflammation ou l’angiogenèse, et sont donc impliquées dans de nombreux aspects de la physiopathologie cardiovasculaire. Les VE semblent avoir une action complexe qui dépend de leur origine et de leur contenu. Bien que leur présence soit parfois délétère, elles sont également considérées comme des outils diagnostiques et thérapeutiques potentiels. Cette revue résume les avancées récentes dans la compréhension du rôle des VE dans les maladies cardiovasculaires.
- 20 December 2021
- Published by EDP Sciences in médecine/sciences
- Vol. 37 (12) , 1119-1124
Open AccessVésicules extracellulaires et maladies cardiovasculaires
Les maladies cardiovasculaires constituent la principale cause de décès dans le monde. Il est donc urgent de développer de nouvelles approches pour le traitement et la détection de ces maladies. Les vésicules extracellulaires (VE) ont attiré une attention considérable au vu de leur rôle dans la communication intercellulaire. Elles régulent en effet des processus clés comme l’inflammation ou l’angiogenèse, et sont donc impliquées dans de nombreux aspects de la physiopathologie cardiovasculaire. Les VE semblent avoir une action complexe qui dépend de leur origine et de leur contenu. Bien que leur présence soit parfois délétère, elles sont également considérées comme des outils diagnostiques et thérapeutiques potentiels. Cette revue résume les avancées récentes dans la compréhension du rôle des VE dans les maladies cardiovasculaires.
- Open Access
- 11 June 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (28) , 2793-2795
Messages from the heart
In aortic stenosis, patients with elevated plasma levels of extracellular vesicles (EVs) of cardiomyocyte origin (CD172+, represented as a green dot) have a more favourable prognosis after transcatheter aortic valve replacement. Although CD172+EVs improve the contractile function of induced pluripotent stem cell-derived cardiomyocytes, it remains unclear to what extent this effect occurs in the patients’ heart. LV, left ventricular. In aortic stenosis, patients with elevated plasma levels of extracellular vesicles (EVs) of cardiomyocyte origin (CD172+, represented as a green dot) have a more favourable prognosis after transcatheter aortic valve replacement. Although CD172+EVs improve the contractile function of induced pluripotent stem cell-derived cardiomyocytes, it remains unclear to what extent this effect occurs in the patients’ heart. LV, left ventricular.
- 11 June 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (28) , 2793-2795
Open AccessMessages from the heart
In aortic stenosis, patients with elevated plasma levels of extracellular vesicles (EVs) of cardiomyocyte origin (CD172+, represented as a green dot) have a more favourable prognosis after transcatheter aortic valve replacement. Although CD172+EVs improve the contractile function of induced pluripotent stem cell-derived cardiomyocytes, it remains unclear to what extent this effect occurs in the patients’ heart. LV, left ventricular. In aortic stenosis, patients with elevated plasma levels of extracellular vesicles (EVs) of cardiomyocyte origin (CD172+, represented as a green dot) have a more favourable prognosis after transcatheter aortic valve replacement. Although CD172+EVs improve the contractile function of induced pluripotent stem cell-derived cardiomyocytes, it remains unclear to what extent this effect occurs in the patients’ heart. LV, left ventricular.
- Open Access
Restoring vascular endothelial autophagic flux reduces atherosclerotic lesions
Atherosclerotic lesions preferentially develop in arterial areas exposed to low shear stress, where endothelial cells express a pro-inflammatory, apoptotic, and senescent phenotype. Endothelial cells exposed to atheroprone low shear stress present a defective autophagic flux, which favors a pro-inflammatory phenotype and the formation of atherosclerotic lesions. We tested the hypothesis that HDAC6 inhibition could restore adequate levels of autophagy in endothelial cells exposed to low shear stress. We found that blocking HDAC6 activity, either by pharmacological inhibition (Tubastatin-A) or genetic approaches (shHDAC6), raised levels of acetylated α-tubulin, as well as LC3-II/I ratio, LC3 puncta area, nuclear TFEB translocation and autophagic flux in cultured endothelial cells exposed to low shear stress. This effect was associated with a reduced expression of inflammatory markers (ICAM-1, VCAM-1 and MCP-1) in TNF-α-stimulated cells. Impaired endothelial autophagic flux was restored in the aortic arch (atheroprone conditions) of HDAC6 -/- mice, when compared to control littermates. Atherosclerotic plaque size was significantly decreased in the aortic arch of chimeric HDAC6 -/- /ApoE -/- mice, transplanted with HDAC6 +/+ /ApoE -/- bone marrow, when compared to HDAC6 +/+ /ApoE -/- littermate controls. Taken together, these results indicate that HDAC6-inhibition may be an interesting strategy to restore endothelial autophagic flux, to help promote an atheroprotective endothelial phenotype despite unfavorable shear stress conditions.
Open AccessRestoring vascular endothelial autophagic flux reduces atherosclerotic lesions
Atherosclerotic lesions preferentially develop in arterial areas exposed to low shear stress, where endothelial cells express a pro-inflammatory, apoptotic, and senescent phenotype. Endothelial cells exposed to atheroprone low shear stress present a defective autophagic flux, which favors a pro-inflammatory phenotype and the formation of atherosclerotic lesions. We tested the hypothesis that HDAC6 inhibition could restore adequate levels of autophagy in endothelial cells exposed to low shear stress. We found that blocking HDAC6 activity, either by pharmacological inhibition (Tubastatin-A) or genetic approaches (shHDAC6), raised levels of acetylated α-tubulin, as well as LC3-II/I ratio, LC3 puncta area, nuclear TFEB translocation and autophagic flux in cultured endothelial cells exposed to low shear stress. This effect was associated with a reduced expression of inflammatory markers (ICAM-1, VCAM-1 and MCP-1) in TNF-α-stimulated cells. Impaired endothelial autophagic flux was restored in the aortic arch (atheroprone conditions) of HDAC6 -/- mice, when compared to control littermates. Atherosclerotic plaque size was significantly decreased in the aortic arch of chimeric HDAC6 -/- /ApoE -/- mice, transplanted with HDAC6 +/+ /ApoE -/- bone marrow, when compared to HDAC6 +/+ /ApoE -/- littermate controls. Taken together, these results indicate that HDAC6-inhibition may be an interesting strategy to restore endothelial autophagic flux, to help promote an atheroprotective endothelial phenotype despite unfavorable shear stress conditions.
- 1 March 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 72 (3) , 528-538
A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis
- 1 March 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 72 (3) , 528-538
A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis
- Open Access
- 1 December 2019
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 18, 363-374
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis
- 1 December 2019
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 18, 363-374
Open AccessLong Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis
- Open Access
- 1 July 2019
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 18, 100620
Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity
- 1 July 2019
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 18, 100620
Open AccessNeuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity
- 1 February 2019
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 39 (2) , 170-177
MicroRNA-21 Deficiency Alters the Survival of Ly-6C lo Monocytes in ApoE −/− Mice and Reduces Early-Stage Atherosclerosis—Brief Report
Objective—: To determine the role of microRNA-21 (miR-21) on the homeostasis of monocyte subsets and on atherosclerosis development in ApoE −/− (apolipoprotein E) mice. Approach and Results—: In ApoE −/− mice, miR-21 expression was increased in circulating Ly-6C lo nonclassical monocytes in comparison to Ly-6C hi monocytes. The absence of miR-21 significantly altered the survival and number of circulating Ly-6C lo nonclassical monocytes in ApoE −/− mice. In the early stages of atherosclerosis, the absence of miR-21 limited lesion development both in the aortic sinus (by almost 30%) and in the aorta (by almost 50%). This was associated with less monocyte availability in circulation and increased apoptosis of local macrophages in plaques. At later stages of atherosclerosis, lesion size in the aortic root was similar in ApoE −/− and ApoE −/− miR-21 −/− mice, but plaques showed a less stable phenotype (larger necrotic cores) in the latter. The loss of protection in advanced stages was most likely because of excessive inflammatory apoptosis related to an impairment of local efficient efferocytosis. Conclusions—: Gene deletion of miR-21 in ApoE −/− mice alters Ly-6C lo nonclassical monocytes homeostasis and contribute to limit early-stage atherosclerosis.
- 1 February 2019
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 39 (2) , 170-177
MicroRNA-21 Deficiency Alters the Survival of Ly-6C lo Monocytes in ApoE −/− Mice and Reduces Early-Stage Atherosclerosis—Brief Report
Objective—: To determine the role of microRNA-21 (miR-21) on the homeostasis of monocyte subsets and on atherosclerosis development in ApoE −/− (apolipoprotein E) mice. Approach and Results—: In ApoE −/− mice, miR-21 expression was increased in circulating Ly-6C lo nonclassical monocytes in comparison to Ly-6C hi monocytes. The absence of miR-21 significantly altered the survival and number of circulating Ly-6C lo nonclassical monocytes in ApoE −/− mice. In the early stages of atherosclerosis, the absence of miR-21 limited lesion development both in the aortic sinus (by almost 30%) and in the aorta (by almost 50%). This was associated with less monocyte availability in circulation and increased apoptosis of local macrophages in plaques. At later stages of atherosclerosis, lesion size in the aortic root was similar in ApoE −/− and ApoE −/− miR-21 −/− mice, but plaques showed a less stable phenotype (larger necrotic cores) in the latter. The loss of protection in advanced stages was most likely because of excessive inflammatory apoptosis related to an impairment of local efficient efferocytosis. Conclusions—: Gene deletion of miR-21 in ApoE −/− mice alters Ly-6C lo nonclassical monocytes homeostasis and contribute to limit early-stage atherosclerosis.
- Top Cited PapersOpen Access
- 23 November 2018
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 7 (1) , 1535750
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell‐released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV‐associated functional activities. Finally, a checklist is provided with summaries of key points.
- 23 November 2018
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 7 (1) , 1535750
Top Cited PapersOpen AccessMinimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell‐released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV‐associated functional activities. Finally, a checklist is provided with summaries of key points.
- Open Access
- 22 June 2018
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 123 (1) , 100-106
Intra-Cardiac Release of Extracellular Vesicles Shapes Inflammation Following Myocardial Infarction
Rationale:: A rapid and massive influx of inflammatory cells occurs into ischemic area after myocardial infarction (MI), resulting in local release of cytokines and growth factors. Yet, the mechanisms regulating their production are not fully explored. The release of extracellular vesicles (EVs) in the interstitial space curbs important biological functions, including inflammation, and influences the development of cardiovascular diseases. To date, there is no evidence for in situ release of cardiac EVs after MI. Objective:: The present study tested the hypothesis that local EV generation in the infarcted heart coordinates cardiac inflammation after MI. Methods and Results:: Coronary artery ligation in mice transiently increases EV levels in the left ventricle when compared with sham animals. EVs from infarcted hearts were characterized as large vesicles (252±18 nm) expressing cardiomyocyte and endothelial markers and small EVs (118±4 nm) harboring exosomal markers, such as CD (cluster of differentiation) 63 and CD9. Cardiac large EVs generated after MI, but not small EVs or sham EVs, increased the release of IL (interleukin)-6, CCL (chemokine ligand) 2, and CCL7 from fluorescence-activated cell–sorted Ly6C + cardiac monocytes. EVs of similar diameter were also isolated from fragments of interventricular septum obtained from patients undergoing aortic valve replacement, thus supporting the clinical relevance of our findings in mice. Conclusions:: The present study demonstrates that acute MI transiently increases the generation of cardiac EVs characterized as both exosomes and microvesicles, originating mainly from cardiomyocytes and endothelial cells. EVs accumulating in the ischemic myocardium are rapidly taken up by infiltrating monocytes and regulate local inflammatory responses.
- 22 June 2018
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 123 (1) , 100-106
Open AccessIntra-Cardiac Release of Extracellular Vesicles Shapes Inflammation Following Myocardial Infarction
Rationale:: A rapid and massive influx of inflammatory cells occurs into ischemic area after myocardial infarction (MI), resulting in local release of cytokines and growth factors. Yet, the mechanisms regulating their production are not fully explored. The release of extracellular vesicles (EVs) in the interstitial space curbs important biological functions, including inflammation, and influences the development of cardiovascular diseases. To date, there is no evidence for in situ release of cardiac EVs after MI. Objective:: The present study tested the hypothesis that local EV generation in the infarcted heart coordinates cardiac inflammation after MI. Methods and Results:: Coronary artery ligation in mice transiently increases EV levels in the left ventricle when compared with sham animals. EVs from infarcted hearts were characterized as large vesicles (252±18 nm) expressing cardiomyocyte and endothelial markers and small EVs (118±4 nm) harboring exosomal markers, such as CD (cluster of differentiation) 63 and CD9. Cardiac large EVs generated after MI, but not small EVs or sham EVs, increased the release of IL (interleukin)-6, CCL (chemokine ligand) 2, and CCL7 from fluorescence-activated cell–sorted Ly6C + cardiac monocytes. EVs of similar diameter were also isolated from fragments of interventricular septum obtained from patients undergoing aortic valve replacement, thus supporting the clinical relevance of our findings in mice. Conclusions:: The present study demonstrates that acute MI transiently increases the generation of cardiac EVs characterized as both exosomes and microvesicles, originating mainly from cardiomyocytes and endothelial cells. EVs accumulating in the ischemic myocardium are rapidly taken up by infiltrating monocytes and regulate local inflammatory responses.